HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Volkow, N. D. Articles by Pappas, N. Search for Related Content PubMed PubMed Citation Articles by Volkow, N. D. Articles by Pappas, N.

A New PET Ligand for the Dopamine Transporter: Studies in the Human Brain

Brookhaven National Laboratory, Upton, New York
Department of Psychiatry, SUNY Stony Brook, Stony Brook, New York

Correspondence: For correspondence or reprints contact: Nora D. Volkow, MD, PhD, Medcial Department, Bldg. 490, Brokhaven National Laboratory, Upton, NY 11973.

ABSTRACT

Carbon-11-d-threo-methylphenidate, the active enantiomer of methylphenidate (ritalin), has been shown to bind uniquely to the dopamine transporter in the baboon brain. This study characterizes its binding in the human brain and measures its test retest reproducibility. Methods: Studies were done in seven normal controls, each of whom was scanned with [¹¹C]d-threomethylphenidate on two different occasions. Six subjects were scanned twice 3–5 wk apart without intervention to assess reproducibiftty. One subject was scanned sequentially before and after treatment with methylphenidate to assess binding saturability. Graphical analysis was used to obtain tissue distribution volumes (DV). The ratio of the DV in the basal ganglia (BG) to that in cerebellum (CB) (DV_BG/DV_CB), which corresponds to (B_max/Kd) + 1 was used to estimate dopamine transporter availability. Results: Highest tracer uptake occurred in the basal ganglia, where activity peaked 7–11 min postinjection. The half-clearance time for the tracer in brain regions other than the basal ganglia was 74 min. In the basal ganglia, only 10%–15% of the activity had cleared at 74 min. Time-activity curves for [¹¹C]d-threo-methylphenidate in the basal ganglia and cerebellum were highly reproducible. The average percent change for the absolute value for DV_BG/DV_CB was 6.5% ± 4% (range 0–12%). Methylphenidate pretreatment decreased basal ganglia uptake but not cortical or cerebellar binding and reduced DV_BG/DV_CB by62% and B_max/Kd by 91%. Conclusion: These studies demonstrate that [¹¹C]d-threo-methylphenidate binding in the human brain is reversible, highly reproducible and saturable. Thus, it is an appropriate PET ligand to measure dopamine transporter availability.

Key Words: carbon-11-d-threo-methylphenidate • dopamine transporter • cocaine • dopamine neurons

This article has been cited by other articles:

				N. D. Volkow, G.-J. Wang, F. Telang, J. S. Fowler, J. Logan, C. Wong, J. Ma, K. Pradhan, D. Tomasi, P. K. Thanos, et al. Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3 Receptors in the Human Brain J. Neurosci., August 20, 2008; 28(34): 8454 - 8461. [Abstract] [Full Text] [PDF]

				C. Leroy, C. Comtat, R. Trebossen, A. Syrota, J.-L. Martinot, and M.-J. Ribeiro Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT J. Nucl. Med., April 1, 2007; 48(4): 538 - 546. [Abstract] [Full Text] [PDF]

				N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, D. Franceschi, M. Sedler, S. J. Gatley, E. Miller, R. Hitzemann, Y.-S. Ding, et al. Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence J. Neurosci., December 1, 2001; 21(23): 9414 - 9418. [Abstract] [Full Text] [PDF]

				N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, M. Leonido-Yee, D. Franceschi, M. J. Sedler, S. J. Gatley, R. Hitzemann, Y.-S. Ding, et al. Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers Am J Psychiatry, March 1, 2001; 158(3): 377 - 382. [Abstract] [Full Text]

				J. Swanson, J. Oosterlaan, M. Murias, S. Schuck, P. Flodman, M. A. Spence, M. Wasdell, Y. Ding, H.-C. Chi, M. Smith, et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention PNAS, April 25, 2000; 97(9): 4754 - 4759. [Abstract] [Full Text] [PDF]